Daria Handkiewicz-Junak
Overview
Explore the profile of Daria Handkiewicz-Junak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Handkiewicz-Junak D, Niedziela M, Lewinski A, Bosowski A, Chmielik E, Czarniecka A, et al.
Endokrynol Pol
. 2025 Jan;
75(6):565-591.
PMID: 39829212
The rapid progress made in recent years in thyroid cancer research has necessitated the systematic updating of current clinical recommendations. This update presents the evidence-based management of differentiated thyroid carcinoma...
2.
Kubeczko M, Polakiewicz-Gilowska A, DAmico A, Chrabanski O, Swiderska K, Chmielik E, et al.
Front Oncol
. 2024 Dec;
14:1454844.
PMID: 39697231
Background: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have demonstrated a survival benefit in the second-line treatment of patients with hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer. However,...
3.
Ledwon A, Kropinska A, Paliczka-Cieslik E, Blewaska A, Sygula A, Olczyk T, et al.
Endokrynol Pol
. 2024 Oct;
75(5):486-493.
PMID: 39475131
Introduction: With an increasing incidence of differentiated thyroid cancer (DTC) diagnosis, questions emerge about the optimal duration of follow-up for detecting recurrent disease and its outcomes. The objective of this...
4.
Handkiewicz-Junak D, Dedecjus M, Ambroziak U, Barczynski M, Bednarek-Papierska L, Chmielik E, et al.
Endokrynol Pol
. 2024 Sep;
75(4):339-358.
PMID: 39279304
Advances in the diagnosis and treatment of adrenocortical carcinoma (ACC), along with the development of new therapeutic and diagnostic methods, have prompted a team of experts to formulate the first...
5.
Namysl-Kaletka A, Wydmanski J, Debosz-Suwinska I, Kaszuba M, Gabrys D, Roch-Zniszczol A, et al.
Curr Oncol
. 2024 Jul;
31(7):4123-4132.
PMID: 39057179
Insulinoma is the most common functional neuroendocrine tumor of the pancreas, with the main clinical symptom being hypoglycemia. The standard treatment is surgery, but some patients are not eligible for...
6.
Kukulska A, Krajewska J, Gawkowska M, Paliczka-Cieslik E, Handkiewicz-Junak D, Kropinska A, et al.
Arch Med Sci
. 2022 Sep;
18(5):1241-1247.
PMID: 36160333
Introduction: The aim of this prospective study was to evaluate long-term outcomes in differentiated thyroid cancer (DTC) patients postoperatively treated with distinct RAI activities of 30 mCi, 60 mCi, and...
7.
Starzynska T, Londzin-Olesik M, Bednarczuk T, Bolanowski M, Borowska M, Chmielik E, et al.
Endokrynol Pol
. 2022 Sep;
73(3):584-611.
PMID: 36059175
Colorectal neuroendocrine neoplasm (CRNEN), especially rectal tumours, are diagnosed with increased frequency due to the widespread use of colonoscopy, including screening examinations. It is important to constantly update and promote...
8.
Bednarczuk T, Zemczak A, Bolanowski M, Borowska M, Chmielik E, Cwikla J, et al.
Endokrynol Pol
. 2022 Sep;
73(3):549-583.
PMID: 36059174
Updated Polish recommendations for the management of patients with neuroendocrine neoplasms (NENs) of the small intestine (SINENs) and of the appendix (ANENs) are presented here. The small intestine, and especially...
9.
Kos-Kudla B, Rosiek V, Borowska M, Bednarczuk T, Bolanowski M, Chmielik E, et al.
Endokrynol Pol
. 2022 Sep;
73(3):491-548.
PMID: 36059173
In this paper, we present the current guidelines for the diagnostics and management of pancreatic neuroendocrine neoplasms (PanNENs) developed by Polish experts providing care for these patients in everyday clinical...
10.
Rydzewska G, Strzelczyk J, Bednarczuk T, Bolanowski M, Borowska M, Chmielik E, et al.
Endokrynol Pol
. 2022 Sep;
73(3):455-490.
PMID: 36059172
After another meeting of experts of the Polish Network of Neuroendocrine Tumours, updated recommendations for the management of patients with gastric and duodenal neuroendocrine neoplasms, including gastrinoma, have been issued....